跳至主要内容
临床试验/ACTRN12620000981921
ACTRN12620000981921已完成未知

Burden of rheumatic heart disease (RHD) and impact of prevention strategies: comprehensive evidence to drive the RHD Endgame

Dr Judith Katzenellenbogen0 个研究点目标入组 42,064 人开始时间: 2020年9月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
42,064

研究概览

简要总结

Analysis still in progress

研究设计

研究类型
Observational

入排标准

年龄范围
Years 至 o limit(—)
性别
All

入选标准

  • The cohort is any person, living or deceased, with a likely diagnosis of rheumatic fever or rheumatic heart disease, as identified by:
  • 1. A record on an Australian ARF/RHD register (has been registered”) or
  • 2. At least one hospital admission (including all public and most private hospitals) with an ICD-10-
  • AM (Australian Modification) code of I00 to I02 (ARF) or I05 to I09 (RHD) in any diagnosis field or
  • 3. A death registry record coded as I00 to I02 (ARF) or I05 to I09 (RHD) or an equivalent free text field (for later periods where the cause of death coding was not available) in any cause of death field.

排除标准

  • Individuals in the linked data set not deemed to have RHD or ARF as defined by the ERASE protocol. This definition has taken into account short comings in ICD coding for RHD. (Please see study protocol attached to this application)

研究者

发起方
Dr Judith Katzenellenbogen

相似试验